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ABSTRACT
The actin-binding protein, gelsolin, is a well known regulator of cancer cell 
invasion. However, the mechanisms by which gelsolin promotes invasion are not well 
established. As reactive oxygen species (ROS) have been shown to promote cancer 
cell invasion, we investigated on the hypothesis that gelsolin-induced changes in ROS 
levels may mediate the invasive capacity of colon cancer cells. 
Herein, we show that increased gelsolin enhances the invasive capacity of colon 
cancer cells, and this is mediated via gelsolin’s effects in elevating intracellular 
superoxide (O2.-) levels. We also provide evidence for a novel physical interaction 
between gelsolin and Cu/ZnSOD, that inhibits the enzymatic activity of Cu/ZnSOD, 
thereby resulting in a sustained elevation of intracellular O2.-. Using microarray 
data of human colorectal cancer tissues from Gene Omnibus, we found that gelsolin 
gene expression positively correlates with urokinase plasminogen activator (uPA), 
an important matrix-degrading protease invovled in cancer invasion. Consistent 
with the in vivo evidence, we show that increased levels of O2.- induced by gelsolin 
overexpression triggers the secretion of uPA. We further observed reduction in 
invasion and intracellular O2.- levels in colon cancer cells, as a consequence of gelsolin 
knockdown using two different siRNAs. In these cells, concurrent repression of Cu/
ZnSOD restored intracellular O2.- levels and rescued invasive capacity.
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INTRODUCTION
Metastasis accounts for 90% of solid tumor 
deaths worldwide [1]. Amongst other factors involved 
in metastasis, invasion of tissues by cancer cells is a 
major determinant and the initial step of metastasis. 
Through attachment to and subsequent degradation of the 
extracellular matrix (ECM), loss of intercellular adhesion, 
enhanced cell motility and resistance to death, cancer cells 
acquire invasive capacity thereby resulting in metastatic 
spread [2,3]. Central to cancer cell migration and invasion 
is the regulation of the actin cytoskeleton. The gelsolin 
superfamily of proteins, in particular gelsolin, is an 
important regulator of the actin cytoskeleton [4]. Owing to 
its regulation of actin filaments via capping and severing, 
gelsolin is believed to promote cell migration and invasion. 
Gelsolin has been shown to translocate to the plasma 
membrane and associate with the actin cytoskeleton. Due 
to this association, the ratio between actin filament and 
monomeric actin is significantly reduced, which promotes 
cell migration [5]. The critical involvement of gelsolin 
in cells’ invasive capacity is further corroborated by the 
findings that cell invasion associated with supervillin, 
another member of the gelsolin superfamily, also involves 
the intermediacy of gelsolin [6]. Multiple cell survival/
proliferation pathways have been implicated in gelsolin-
induced migration and invasion, namely Ras-PI3K-Rac 
network [7], epidermal growth factor (EGF) [8] and erbB-
2/EGFR (epidermal growth factor receptor) [9] pathways.
Cellular protrusions such as lamellipodia, filopodia 
and invadopodia are critical invasive structures that form 
the leading edge of invading cells in cancer [10]. Gelsolin 
has been shown to play an important role in the EGF-
induced cell migration by participating in lamellipodia 
formation [8]. Gelsolin has also been shown to be 
important for the formation of podosomes in osteoclasts 
[11], the equivalent structure of invadpodia in non-
cancer cells. The role of gelsolin in cellular protrusions 
can therefore be attributed to its regulation of the actin 
cytoskeleton. Invasive front in cancer cells are enriched 
with proteases such as the matrix metalloproteinases 
(MMPs) and the urokinase plaminogen activator (uPA) 
that aid in the degradation of the ECM [12,13]. We 
have previously reported that gelsolin overexpression 
enhances the production and secretion of uPA, thereby 
promoting invasion in colon cancer cells [14]. Our finding 
makes it tempting to speculate a critical role of gelsolin 
in proteolysis at the invasive front of cancer cells. In 
addition, it also points to an aspect of gelsolin which 
may be distinct from its actin regulation. The molecular 
mechanism by which gelsolin contributes to protease 
secretion remains poorly understood.
Reactive oxygen species (ROS) are chemically 
active molecules formed by the incomplete reduction 
of oxygen (O2). Superoxide (O2.-), the precursor ROS is 
generated through enzymatic action of NADPH oxidase 
(Nox) or as a metabolic by-product of mitochondrial 
respiration. Subsequent reactions can give rise to the 
formation of other types of ROS such as hydrogen 
peroxide (H2O2), hydroxyl radical (.OH) and hypochlorous 
acid (HOCl). Under normal physiological conditions, 
redox homeostasis is maintained by the efficient cellular 
antioxidant systems [15]. Whereas, overwhelming 
oxidative stress is invariably associated with cell and tissue 
damage and/or death, there is accumulating evidence to 
implicate mild oxidative stress with cellular proliferation, 
growth and survival. In this regard, an imbalance between 
ROS production and anti-oxidant defense mechanisms 
has been shown to promote cell transformation and 
oncogenesis [16,17]. In fact, the myriad of signaling 
networks engaged by a pro-oxidant cellular milieu also 
provides the cells with the ability to migrate and invade, 
thereby favoring the progression of the disease [18]. Of 
note, there is recent evidence to implicate ROS-mediated 
regulation of the actin cytoskeleton dynamics in enhanced 
migration and invasion [19,20]. For example, intracellular 
O2.- is implicated in the small GTPase Rac1 mediated 
increase in actin polymerization. Pharmacological 
inhibition of intracellular ROS production with the 
Nox inhibitor diphenyleneiodonium (DPI), as well as 
the use of ROS scavengers such as manganese (III) 
tetrakis (1-methyl-4-pyridyl) porphyrin (MnTMPyP), 
abrogates actin filament elongation [21], thus suggesting 
the involvement of ROS in actin cytoskeletal dynamics. 
Furthermore, studies have also indicated that the actin 
cytoskeleton may initiate ROS generation, actin assembly 
was shown to enhance O2.- production in eosinophils [22]. 
Stabilization of the Nox complex as well as recruitment 
of Nox subunits are also known to be influenced by the 
actin cytoskeletal proteins [23-25]. These findings provide 
testimony that, in addition to providing structural support, 
actin and its associated proteins may be engaged in ROS 
generation that promotes cancer cell invasion. Stimulated 
by these findings, here we hypothesized that gelsolin, a 
key actin regulatory protein, may contribute to the control 
of ROS levels in cancer cells. In this study, we provide 
evidence that the expression of gelsolin promotes invasion 
via mechanisms that involve an increase in intracellular 
O2.- in HCT116 colon cancer cells. Gelsolin suppresses the 
enzymatic activity of Cu/ZnSOD, thereby resulting in an 
accumulation of O2.- in the cells. Bioinformatic analysis 
Our study therefore identified gelsolin as a novel regulator of intracellular O2
.- in 
cancer cells via interacting with Cu/ZnSOD and inhibiting its enzymatic activity. Taken 
together, these findings provide insight into a novel function of gelsolin in promoting 
tumor invasion by directly impacting the cellular redox milieu.
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and in situ approaches reveal the existence of a protein-
protein interaction between gelsolin and Cu/ZnSOD 
that might account for the inhibition of the enzymatic 
activity. Thus, our findings provide a novel mechanism 
by which gelsolin mediates colon cancer cell invasion via 
modulating intracellular O2.- levels.
RESULTS
Intracellular O2.- levels are modulated by gelsolin 
expression in cells
We first sought to determine if gelsolin affects 
intracellular levels of ROS such as O2.- , H2O2, .OH and 
HOCl. Using the chemiluminescent based lucigenin assay 
and the cell permeable dihydroethidium (DHE) dye, 
we assessed the changes in intracellular O2.- levels with 
increased expression of gelsolin. Under normal growth 
conditions, the level of O2.- was significantly elevated in 
cells stably overexpressing gelsolin (C1 and C8 cells) 
when compared to control cells stably transfected with the 
empty vector (Figures 1A & S1A). Furthermore, siRNA 
mediated gene silencing of gelsolin in HCT116, RKO, 
HeLa and HepG2 cells resulted in a significant decrease 
in intracellular O2.- levels (Figures 1B, S1B & C). Taken 
together, these data provide evidence to link gelsolin 
expression to an increase in intracellular O2.- levels.
Previous studies have shown that several ROS 
including H2O2, .OH and HOCl can oxidize 5-(and-6)-
chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate 
acetyl ester (CM-H2DCFDA) [26-29]. Hence, gelsolin 
was depleted in several cancer cell lines including 
HCT116, RKO, Caco-2, DLD-1, HeLa and HepG2 and 
CM-H2DCFDA oxidation assay was performed. However, 
there was no significant change in CM-H2DCFDA 
intensity between gelsolin-knockdown and the control 
siRNA-treated cells (Figure S2A). This indicates that 
gelsolin is minimally involved in modulating H2O2, .OH 
and HOCl levels in these cancer cells. In addition, the 
Amplex Red H2O2 assay was used to detect H2O2 levels 
Figure 1: Gelsolin modulates intracellular superoxide (O2.-) levels. (A) Left panel: Western blot showing overexpression of 
gelsolin in HCT116 cells. Right panel: Intracellular O2.- levels were measured using the chemiluminescent-based lucigenin assay. Gelsolin-
overexpressing cells (C1&C8) show significantly higher levels of O2
.- when compared to the empty vector control cells. (B) Left panel: 
Western blot showing gelsolin-knockdown in HCT116 and RKO cells using two different siRNAs (Gsn si (b) & Gsn si) targeting gelsolin 
in HCT116 and a single siRNA (Gsn si) in RKO cells. Right panel: Silencing of gelsolin in HCT116 and RKO cells results in decreased 
levels of O2.- when compared to the control siRNA. O2.- data shown are mean ± SD of at least three independent experiments. *p-value <0.05 
versus controls using a two tailed Student’s t-test. Values (mean ± SD ) are expressed as fold over the empty vector control or the control 
siRNA, which is arbitrarily set to one. The western blot gel pictures are representative images from three independent experiments. 
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in gelsolin-overexpressing cells. The Amplex Red reagent 
reacts with H2O2 resulting in a red fluorescent oxidation 
product which could be assayed fluorometrically. Again, 
no significant difference was observed in H2O2 levels 
when gelsolin expression was increased, compared to 
the empty vector transfected cells (Figure S2B). Taken 
together, these data suggest that gelsolin overexpression 
may specifically modulate only the levels of intracellular 
O2.-.
Gelsolin modulates O2.- levels by suppressing Cu/
ZnSOD activity
Antioxidants play important roles in maintaining 
the cellular redox homeostasis, therefore, abnormal 
fluctuations in the antioxidant system significantly 
alters the ROS-antioxidant balance resulting in redox 
dyshomeostasis [30]. An important determinant of 
increased O2.- levels in cells is the loss of enzymatic 
activity of the antoxidant Cu/ZnSOD [31]. As such, we 
questioned whether the increase in intracellular O2.- upon 
overexpression of gelsolin was a function of a compromise 
in the enzymatic activity of Cu/ZnSOD. To assess that, 
SOD activity was first measured in total cell lysate (this 
is the combined enzymatic activities of the two SOD 
isoforms , Cu/ZnSOD and MnSOD). Indeed, total SOD 
activity was significantly lower in the two cell lines 
overexpressing gelsolin, (C1 and C8), compared to the 
empty vector transfected and wild-type HCT116 cells 
(Figure 2A). Similarly, depletion of endogenous gelsolin 
expression in wild-type HCT116 results in higher total 
SOD activity, relative to the control siRNA transfected 
cells (Figure 2B).
In order to identify the SOD isoform targeted 
by gelsolin, we performed subcellular fractionation 
experiment that separates the cytosol from intact 
mitochondria. Cu/ZnSOD and MnSOD activities were 
assayed from the respective fractions. The validity of our 
fractionation was confirmed by the presence of Cu/ZnSOD 
and GAPDH in the cytosol and MnSOD and VDAC in 
the mitochondrial fractions, whilst β-actin was used as the 
internal loading control for both fractions (Figure 2C & 
2D). Gelsolin-overexpressing C1 and C8 cells displayed 
lower Cu/ZnSOD activity compared to empty vector 
control and wild-type HCT116 cells (Figure 2E), whereas 
Cu/ZnSOD activity was significantly elevated following 
gelsolin knockdown in both HCT116 and C1 cells (Figure 
2F). However, MnSOD activity was only minimally 
affected by the modulation of gelsolin expression as shown 
in Figure 2G & 2H. These results indicate that changes 
in gelsolin expression alter Cu/ZnSOD activity but not 
MnSOD activity, and therefore the reduction of total SOD 
activity observed in figure 2A is mainly accounted by the 
loss of Cu/ZnSOD activity. It should be pointed out that 
changes in enzymatic activites could be influenced by 
protein expression; however the protein levels of both Cu/
ZnSOD and MnSOD were not affected upon modulation 
of gelsolin expression (Figure 2C & 2D).
In silico analysis of gelsolin and Cu/ZnSOD 
interaction
In our attempt to explore how gelsolin suppresses 
Cu/ZnSOD activity, we tested the possibility of a protein-
protein interaction between gelsolin and Cu/ZnSOD. 
Docking analysis using PatchDock was performed 
between gelsolin (PDB: 3FFN, chain A) [32] and Cu/
ZnSOD (PDB: 1PU0 Chain A) [33], which suggested 
the presence of a direct interaction between gelsolin and 
Cu/ZnSOD (Figure S3A). In addition, we identified the 
amino acid residues involved in the interaction (Figure 
3A-C), which also provided evidence that the C-terminus 
of gelsolin is important in its interaction with Cu/ZnSOD 
(Figure 3B). The amino acid residues 736, 737, 739 
and 752 of gelsolin were predicted to form polar bonds 
with the amino acid residues 68, 136, 136 and 122 of 
Cu/ZnSOD, respectively. Using Pymol, a molecular 
visualization tool, the distances between the predicted 
interacting amino acid residues were found to be less than 
2 angstroms (Figure 3A), suggesting that these amino 
acid residues are in close spatial proximity, and thus polar 
bonds can possibly form between these two proteins. 
Moreover, the predicted amino acid residues within Cu/
ZnSOD that participate in the complex formation lie very 
close to the enzymatic active site of Cu/ZnSOD [34] (at 
amino acid positions 47,49,64,81,84,121 [http://www.
ncbi.nlm.nih.gov/protein/CAG46542.1]) (Figure 3C). It 
is therefore probable that the complex formation and the 
3-dimensional folding of the proteins hinder the catalytic 
activity of Cu/ZnSOD. Moreover, the stability of the 
docked gelsolin-Cu/ZnSOD complex was analyzed with 
molecular dynamics simulation that mimics physiological 
conditions. Molecular dynamics simulation shows that the 
gelsolin-Cu/ZnSOD complex structure remains intact for 
up to 10 nanoseconds (Figure S3B). Taking together, our 
in silico analysis suggests that gelsolin and Cu/ZnSOD 
are potential binding partners, and they likely form stable 
complexes under physiological conditions. Considering 
the predicted binding site on Cu/ZnSOD catalytic site, it 
is possible that the potential interaction with gelsolin may 
influence Cn/ZnSOD activity.
Gelsolin interacts with Cu/ZnSOD in situ and in 
vitro
To validate our in silico analysis, we performed 
an in situ proximity ligation assay (PLA) as well as 
coimmunoprecipitation (Co-IP) studies between gelsolin 
and Cu/ZnSOD. Permeabilized cells were treated with 
primary antibodies against gelsolin and Cu/ZnSOD 
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Figure 2: Gelsolin modulates SOD activity. (A & B) Total intracellular SOD activity was measured from total cell lysates. Increased 
gelsolin expression lowers the SOD activity in both C1 and C8 cells as compared to wild type HCT116 and empty vector control cells. (B) 
Knockdown of endogenous gelsolin in HCT116 cells shows increased SOD activity when compared to the control siRNA treated cells. (C 
& D) Cytosolic and mitochondrial fractions were isolated in HCT116 cells following either gelsolin overexpression or gelsolin knockdown. 
Fractionation was confirmed by the presence of MnSOD and VDAC in the mitochondria and Cu/ZnSOD and GAPDH in the cytosol. β-actin 
was used as the internal loading control. (E & F) Cu/ZnSOD activity was measured from the cytosolic extract. Gelsolin overexpression 
results in suppression of Cu/ZnSOD activity when compared to the empty vector control cells whereas knockdown of gelsolin in HCT116 
and C1 cells results in elevated Cu/ZnSOD activity. (G & H ) MnSOD activity was determined from the mitochondrial fraction. No 
significant change in MnSOD activity was observed when gelsolin was overexpressed or silenced in HCT116 and C1 cells. *p-value <0.05 
versus controls using a two tailed Student’s t-test. Values (mean ± SD ) are expressed as fold over the empty vector control or the control 
siRNA, which is arbitrarily set as one. The western blot gel pictures are representative images from three independent experiments. 
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followed by treatment with secondary antibody probes. 
The probes are attached to short DNA strands or oligos. 
If the two proteins interact with each other, the oligos 
from both the probes ligate, and upon amplification 
emit a fluorescent signal. The close association between 
gelsolin and Cu/ZnSOD was confirmed upon detection of 
the PLA signal in red fluorescence, which was visualized 
using fluorescent microscopy at 563nm (Figure 4A). 
The intensity of the red signal observed in C1 cells 
(overexpressing gelsolin) are higher compared to the 
vector control cells, thus indicating a greater association 
between gelsolin and Cu/ZnSOD. Negative controls 
such as treatment with isotype antibody and single 
specific primary antibody (ie. either anti-gelsolin or anti-
Cu/ZnSOD antibody alone) were included to confirm 
the specificity of the assay. No red fluorescent signals 
were detected in the negative control sets (Figure S4). 
Importantly, when we depleted gelsolin expression in C1 
cells, the intensity of the red signal became significantly 
weaker in gelsolin-knockdown cells, relative to the control 
siRNA-treated cells (Figure 4B). To further confirm 
if gelsolin interacts with Cu/ZnSOD, endogenous Cu/
Figure 3: In silico analysis of gelsolin and Cu/ZnSOD interaction. (A) 3-dimensional structure of gelsolin-Cu/ZnSOD complex 
was obtained using PatchDock analysis. The green structure corresponds to gelsolin (PDB: 3FFN, chain A) and the yellow structure 
represents the Cu/ZnSOD structure (PDB: 1PU0 Chain A). The interacting region of the complex structure of Gelsolin-Cu/ZnSOD was 
analyzed using PyMol software. The interacting residues were identified and the distance between these residues were calculated and 
represented in angstrom. (B) Cartoon model of gelsolin structure with domains and the C-terminal tail region. The C-terminal tail region 
of gelsolin is important for its interaction with Cu/ZnSOD. Four of the amino acids at positions 736, 737, 739 and 752 of the C-terminal 
tail region of gelsolin participate in the complex formation with Cu/ZnSOD. (C) The predicted amino acid residues (positions 58, 68, 136 
and 122) of Cu/ZnSOD that participate in its interaction with gelsolin lie close to the active sites of the Cu/ZnSOD (47,49,64,81,84,121) 
in the 3-Dimesional structure.
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ZnSOD was immunoprecipitated from the lysate of C1 
cells. The presence of gelsolin in the immunoprecipitate 
was detected by western blot (Figure 4C), thus confirming 
that there is physical interaction between the two proteins.
Gelsolin mediates colon cancer cell invasion via 
modulating the intracellular O2.- levels
We have previously shown that increased gelsolin 
expression promotes colon cancer cell invasion through 
its involvement in the secretion and increased activiy 
of uPA [14]. To understand the involvement of gelsolin 
Figure 4: Gelsolin forms a complex with Cu/ZnSOD. (A-B) Proximity ligation assay (PLA) was performed in gelsolin-
overexpressing and gelsolin-knockdown cells. PLA signals in red fluorescence were detected when cells were treated with both gelsolin 
and Cu/ZnSOD antibodies. Nuclei were counterstained with DAPI. Images were captured using Olympus DP72 microscope and cellSens 
software at 40X. (C) Endogenous Cu/ZnSOD was immunoprecipitated from lysates of C1 cells using Cu/ZnSOD antibody. Cu/ZnSOD and 
gelsolin were detected in the western blot using specific antibodies against Cu/ZnSOD and gelsolin as shown in lanes 2 and 4. The negative 
mouse IgG control in lanes 1 and 3 does not detect any protein band. Lane 5 shows the protein expression of gelsolin and Cu/ZnSOD in the 
C1 cell lysate. Data shown here is a representative of three independent experiments.
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in uPA-mediated invasion in colorectal cancer in vivo, 
we analyzed the correlation between gelsolin and uPA 
gene expression. Based on the microarray data of tumor 
tissues from Gene Omnibus (GEO), gene expression of 
gelsolin showed a signifcant positive correlation with uPA 
in colorectal cancer (Figure 5A). Furthermore, gelsolin 
expression was found to correlate with several genes 
involved in epithelial–mesenchymal transition (EMT) 
(Figure S5), a process promoting invasion [35]. These 
data strongly support the pro-invasive role of gelsolin in 
colorectal cancer.
To gain a deeper understanding of the role of 
geloslin in invasion, we tested if its regulation of O2.- 
contributes to gelsolin-mediated invasion. We used 5µM 
diphenyleneiodonium(DPI), a potent inhibitor of Nox [36] 
to inhibit O2.- production in the cells. Treatment of cells 
with 5µM DPI significantly abrogated O2
.- production 
in gelsolin-overexpressing C1 and C8 cells (Figure 5B). 
The role of O2.- in gelsolin-mediated invasion was further 
assessed using a transwell invasion assay, performed under 
similar conditions of DPI treatment. Consistent with the 
reduction in O2.- levels, the invasive capacity of gelsolin-
Figure 5: DPI inhibits gelsolin-induced O2.- invasion and uPA levels. (A) Correlation of gelsolin expression with uPA across 
1820 colorectal cancer samples. Spearman’s rank correlation test was used to access the correlation of uPA expression with gelsolin. The 
correlation coefficient (ρ) and its significance (P value) are indicated. (B-D) Treatment of cells with 5µM DPI for 24 hours significantly 
lowered (B) O2.- levels and (C) invasion of gelsolin-overexpresing cells and (D) gelsolin-induced uPA secretion. Upper panel B, quantitative 
representation of invaded cells following 5µM DPI treatment. Lower panel B, representative pictures of invaded cells with or without DPI 
treatments are shown (2.5X magnification of the entire well). *p-value <0.05 versus controls using a two tailed Student’s t-test. Values 
(mean ± SD ) are expressed as fold over the empty vector control, which was arbitrarily set as one. (D) Cells were serum starved with or 
without 5µM DPI for 8 hours and the conditioned media were used to detect uPA by ELISA. Treatment of cells with 5µM DPI significantly 
inhibited uPA secretion in the gelsolin-overexpressing C1 cells whereas 5µM DPI treatment minimally affected uPA secretion in the empty 
vector control and wild-type HCT116. Secreted uPA levels were normalized to protein concentration. The data shown here is the raw ELISA 
reading and a representative of three independent experiments.
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overexpressing cells was significantly decreased following 
DPI treatment (Figure 5C). It should be pointed out that 
the reduction in invasion observed upon DPI treatment 
was not due to reduction in cell viability as assessed using 
the trypan blue dye exclusion method; 5µM DPI for 24 
hours had minimal effect on cell viability (Figure S6). We 
also tested if O2.- participated in enhancing uPA secretion 
induced by gelsolin. Cells were serum starved with or 
without 5µM DPI for 8 hours and the conditioned media 
were used for the detection of uPA by ELISA. Treatment 
of cells with DPI significantly inhibited uPA secretion in 
C1 cells, whereas similar treatment had a minimal effect 
on the empty vector transfected and wild-type HCT116 
cells (Figure 5D). We also confirmed that the cell viability 
was not affected by the DPI treatment (Figure S7). Taken 
together, these data implicate the role of intracellular O2.- 
in gelsolin-induced tumor cell invasion and uPA secretion.
To confirm the requirement of O2
.- in tumor cell 
invasion, we asked if an increase in O2.- could phenocopy 
the effect of gelsolin in cells where the expression of 
gelsolin had been repressed by siRNA-mediated gene 
silencing. Therefore, the expression of Cu/ZnSOD was 
silenced by siRNA in gelsolin-depleted cells. Silencing 
of Cu/ZnSOD abrogated the conversion of O2.- to H2O2 
thus leading to increased accumulation of O2.- even in the 
absence of gelsolin. Knockdown of gelsolin alone resulted 
in a decrease in intracellular O2.-, however, simultaneous 
knockdown of gelsolin and Cu/ZnSOD restored O2.- levels 
in gelsolin-depleted cells (Figure 6A & 6B). Similarly, 
knockdown of gelsolin results in decreased invasion, 
however, simultaneous knockdown of Cu/ZnSOD and 
gelsolin was able to restore invasion in gelsolin-depleted 
cells (Figure 6C). These data provide strong evidence to 
link intracellular O2.- to the invasive capacity of tumor cells 
as well as underpin the requirement of O2.- in gelsolin-
induced cancer cell invasion.
Figure 6: O2.- rescues invasion in gelsolin-depleted cells. O2.- levels were induced in gelsolin-knockdown cells by silencing Cu/
ZnSOD in wild-type HCT116 cells. (C) Western blot showing knockdown of gelsolin and Cu/ZnSOD in HCT116 cells. (B) Simultaneous 
knockdown of gelsolin and Cu/ZnSOD significantly increases O2
.- levels in gelsolin-depleted cells. (C) Increasing O2.- levels by knockdown 
of Cu/ZnSOD rescues invasion in gelsolin-depleted HCT116 cells. Data shown are mean ± SD of at least three independent experiments. 
*p-value <0.05 versus controls using a two tailed Student’s t-test. Values (mean ± SD ) are expressed as fold over the empty vector 




The role of gelsolin in cancer has been controversial 
due to conflicting evidence suggesting gelsolin’s role as 
a tumor suppressor or activator. The tumor suppressive 
role of gelsolin is mostly linked to its downregulation 
in several cancers including breast [37], colon [38], 
stomach [39], bladder [40], prostate [41], lung [42] as 
well as in transformed human fibroblast and epithelial 
cells [43]. Conversely, a number of studies have shown 
the tumorigenic potential of gelsolin [44-47], including 
our report on gelsolin’s role in inducing uPA secretion 
to promote tumor cell invasion [14]. In this study, we 
explored the mechanisms by which gelsolin exert its 
oncogenic behaviour, specifically in promoting the 
invasive phenotype. We provide evidence that increased 
gelsolin expression in HCT116 cells creates a pro-oxidant 
milieu and promotes tumor cell invasion.
Oxidative stress has been shown to be associated 
with aggressive phenotypes in cancer cells [48,49] and 
cancer cell fate decisions are regulated by the cellular 
redox environment. Whilst a sublethal increase in oxidants 
may promote cancer cell growth, proliferation and 
invasion, excessively high oxidative stress is associated 
with cell and tissue injury and death [50-52]. We show 
that overexpression of gelsolin generates a sublethal level 
of oxidative stress that confers an invasive phenotype. 
Blockade of O2.- production with DPI attenuated the 
invasive capacities of gelsolin-overexpressing cells as well 
as lowering gelsolin-induced uPA secretion, implying the 
critical intermediacy of O2.- in gelsolin-induced invasion. 
In addition to cancer cell invasion, the oncogenic property 
of O2.- has been evidenced through earlier studies that 
linked oncogene-induced cell survival and proliferation 
to an increase in intracellular O2.- [53-56]. Our findings 
thus corroborate the oncogenic behavior of O2.- in that it 
facilitates gelsolin-induced invasion in HCT116 cells.
ROS have been implicated in the alteration of 
the tumor microenvironment. ROS are well known 
transcriptional activators of ECM enzymes, such as uPA 
and MMP family of proteases [57,58]. In addition, ROS 
can also directly activate MMPs by oxidative modification 
of the cysteine residue [59,60]. However, the effect of 
intracellular ROS on the enzymatic activity of uPA is not 
well understood. We have previously reported that gelsolin 
upregulated the mRNA and protein levels of uPA as well as 
induced its enzymatic activity [14]. Moreover, our clinical 
data from colorectal cancer patient gene expression 
profiles reveals a positive corelation between gelsolin 
expression and uPA expression, suggesting a clinical 
significance of gelsolin in promoting cancer invasion. 
Results presented in this report not only corroborate our 
earlier findings, but also provide a mechanistic insight 
into the effect of gelsolin on uPA expression and activity 
by demonstrating the requirement of intracellular O2.- in 
gelsolin-induced uPA upregulation. Furthermore, gelsolin-
induced uPA secretion and invasion could be dramatically 
attenuated upon pharmacological inhibition of Nox with 
DPI. Although, a number of downstream targets of ROS in 
cancer has been reported, the upstream events that regulate 
ROS are not well characterized. Our study reveals gelsolin 
as a novel upstream inducer of O2.- in cancer cells as well 
as provide evidence to link gelsolin-induced invasion 
to an increase in intracellular O2.-. Taken together, our 
study provides in-depth mechanism in gelsolin-mediated 
invasion through modulating intracellular O2.- levels to 
enhance uPA secretion and invasion, and this pathway 
may contribute to invasion and dissemination of cancer in 
colorectal cancer patient.
By keeping a tight check on the cellular oxidant 
levels, antioxidants protect cells against oxidant mediated 
insults. Interestingly, a pro-oxidant intracellular milieu 
is typically associated with cancer cells, which has been 
attributed in part to the downregulation of antioxidant 
defense systems in transformed or malignant cells. For 
example, downregulation of the three major antioxidants 
Cu/ZnSOD, MnSOD and catalase have been reported in 
prostate cancer [61]. On the other hand, overexpression 
of Cu/ZnSOD, MnSOD and catalase lowered both the 
growth rate as well as the aggressive nature of breast 
cancer cells [48,49]. SODs act by dismutating O2.-to 
H2O2 [62], thereby acting as a first line of defense in 
cells. Whilst the enzymatic functions of the two isoforms 
of SOD, the cytosolic Cu/ZnSOD and mitochondrial 
MnSOD, are similar, their site of action is restricted by 
their sub-cellular localization. Cu/ZnSOD is responsible 
for eliminating O2.- in the cytosol and MnSOD scavenges 
O2.- in the mitochondria [17]. Our results point to the 
suppression of cytoplasmic Cu/ZnSOD activity, but 
not of its mitochondrial counterpart, MnSOD, which 
accounts for the rise in the intracellualr levels of O2.- in 
gelsolin-overexpressing cells. Cu/ZnSOD activity is 
controlled by several factors including copper loading 
via the chaperone protein CCS (Copper chaperone for 
Cu/ZnSOD), dimerization of the Cu/ZnSOD molecules 
and structural stability offered by zinc ions [63,64]. 
Besides the biochemical influences, Cu/ZnSOD activity 
is also determined by its transcriptional regulation and 
protein expression. In this study, we identified gelsolin 
as a new regulator of Cu/ZnSOD by directly interacting 
with and inhibiting its enzymatic function. Our results 
were substantiated by in silico analysis, Co-IP as well as 
PLA data that confirm the existence of a protein-protein 
interaction between gelsolin and Cu/ZnSOD under basal 
cell culture conditions. Further analysis of this interaction 
from our in silico data suggested that the predicted amino 
acid residues of Cu/ZnSOD that participate in the complex 
lie close to the enzymatic active sites of Cu/ZnSOD. 
Judging from the docked gelsolin-Cu/ZnSOD complex 
structure, Cu/ZnSOD is positioned in a way that both the 
predicted interacting amino acid residues and the active 
sites of Cu/ZnSOD (residues 47,49,64,81,84 and 121) 
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faced the groove of the relatively bigger gelsolin molecule 
and perhaps buried itself into this grove. Considering 
the relative difference in the molecular sizes of gelsolin 
(85Kda) and Cu/ZnSOD (18Kda) and the orientation of 
the molecules, it is plausible that this interaction masks the 
enzymatic activity of Cu/ZnSOD, which in turn results in 
an increase in O2.- levels. 
Structurally, gelsolin is made up of six domains 
(G1-G6) that are arranged as tandem repeats [65]. 
Attached to domain six is the C-terminal tail that plays 
a pivotal role in regulation of actin binding capability of 
gelsolin. The C-terminal segment of gelsolin binds to actin 
in the presence of calcium, while binding of N-terminal 
segment is controlled by both calcium and the C-terminal 
tail. In the absence of calcium, however, the tail binds G2 
(the second gelsolin repeat present in N-terminal half of 
gelsolin) and prevents binding to actin [66,67]. Calcium 
is a critical molecule involved in ROS production [68-
70], however, we did not observe significant differences 
in calcium levels between vector control and gelsolin-
overexpressing cells (Figure S8), indicating that gelsolin 
may not regulate calcium levels in our model. From our in 
silico analysis, it is interesting to note that the C-terminal 
tail region of gelsolin is likely to be crucial in its binding 
to Cu/ZnSOD. Interestingly, residues 736, 737, 739 
and 752 in gelsolin identified from in silico analysis as 
potential Cu/ZnSOD binding sites all lie at the tail region. 
Considering the importance of the tail region of gelsolin 
in its actin-binding regulation, it would be interesting to 
study if the interaction between gelsolin and Cu/ZnSOD 
could affect the actin-regulation ability of gelsolin. Taken 
together, in silico analysis of the interaction sites between 
gelsolin and Cu/ZnSOD reveals that the binding may 
affect the activities of both gelsolin and Cu/ZnSOD, and 
it might be interesting to study if the interaction could 
influence the activities of both proteins which in turn 
affect the invasive capacity of cancer cells.
In conclusion, our study shows a mechanistic insight 
into the role of gelsolin in cancer cell invasion. Notably, 
we have delineated a new role of gelsolin in creating a 
pro-oxidant milieu that favors tumor cell invasion. We 
further demonstrate a novel protein-protein interaction 
between gelsolin and the antioxidant Cu/ZnSOD, which 
appears to inhibit Cu/ZnSOD activity, leading to increased 
O2.- levels. Disruption of the gelsolin-Cu/ZnSOD complex 
by small molecules would restore Cu/ZnSOD activity 
thereby reducing intracellular levels of O2.- which could 
have potential implications for the design of therapeutic 
strategies to combat tumor invasive capacity.
MATERIALS AND METHODS
Cell lines and culture conditions
Human colorectal cancer cell lines HCT116, RKO, 
Caco-2 and DLD-1 were obtained from ATCC (Manassas, 
VA, USA). HCT116 was cultured in McCoy’s 5A modified 
medium; RKO, HeLa and HepG2 cells were cultured in 
Dulbecco’s Modified Eagle’s Medium (DMEM). McCoy’s 
5A and DMEM were purchased from Sigma-Aldrich, LO, 
USA. Stable HCT116 cell lines overexpressing gelsolin, 
namely C1 and C8 as well as empty vector control cells 
were grown in McCoy’s 5A supplemented with 500 μg/
mL Geneticin G418 (Gibco, NY, USA). All the media 
were supplemented with 10% fetal bovine serum (FBS) 
(Hyclone, UK). Cells were maintained at 37oC in a 
humidified incubator with 5% CO2.
Cell transfection
Stable cell lines overexpressing gelsolin (C1 and 
C8) were previously derived from HCT116 cells in our 
laboratory [14].
Two siRNA duplex oligonucleotides 
AAACGUCCAAUCUUGUUGGAGCAGG and 
TAGAACTGTCCATATGTGGCAGGGT (Life 
Technologies, Carlsbad, CA, USA) at 10nM were 
used to silence the expression of gelsolin, and the 
oligonucleotides CCATGCAGGTCCTCACTTTA 
(Qiagen, Hilden, Germany) was used for the silencing of 
Cu/ZnSOD following the manufacturer’s protocol. Non-
targeting siRNA control with medium GC content (Life 
Technologies) was used as a negative control for gelsolin, 
and an all star negative control siRNA (Qiagen) was used 
as a negative control for Cu/ZnSOD. To control for double 
knockdown, cells were treated with both the control 
siRNAs (medium GC and all star negative).
Determination of intracellular ROS 
Total intracellular superoxide was measured using 
the chemiluminescence-based lucigenin method as 
described [71]. Cells were cultured in complete media 
under normal growth conditions. Pelleted cells were 
lysed with somatic cell ATP-releasing agent (Sigma-
Aldrich, LO, USA). 400µL of the lysate was immediately 
transferred to a glass tube and chemiluminescence was 
monitored using a Berthold Sirius Luminometer. Data 
were described as Relative Light Units/second/milligram 
of protein (RLU/s/mg protein). Readings were normalized 
with protein concentration.
DHE and CM-H2DCFDA staining were performed 
to detect O2.- and other ROS respectively. Cells 
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were loaded with either DHE/CM-H2DCFDA (Life 
Technologies) at a final concentration of 10µM at 37ºC for 
10 min and analysis was carried out with flow cytometry 
(BD Facs Calibur/Cyan ADP Beckman Coulter) with 
excitation/emission at 488/518nm for CM-H2DCFDA and 
530/610nm for DHE. Data were analyzed using the Cell 
Quest Pro and Summit softwares.
Specific H2O2 levels in gelsolin-overexpressing cells 
were analysed using the Amplex Red Hydrogen Peroxide/
Peroxidase Assay Kit (Life Technologies). Cells were 
lysed and 20µL of cell lysate was dispensed in a well of 
96-well plate and Amplex Red reagent mix was added 
to the samples. Fluorometric reading was immediately 
determined using Varioskan fluorometric reader at 585nm. 
Data was normalized to protein concentration.
Cell viability assay
Cells were cultured with or without 5µM DPI 
(Sigma-Aldrich) for 24 h (in medium containg 1% FBS) 
or 8 h (in serum-free medium). Cells were then trypsinized 
and number of viable cells were counted using trypan blue 
exclusion method.
Matrigel invasion assay
Matrigel invasion assay was performed using the BD 
Matrigel Basement Membrane Matrix (BD Biosciences, 
CA, USA). 40µL of diluted matrigel (0.33mg/mL, diluted 
in serum free media) was coated on a 8-μm pore size 
6.5-mm diameter transwell filter membrane (Corning, 
NY, USA). The matrigel was allowed to polymerize 
at 37oC for 2 h. 2 x 105 cells with or without 5µM DPI 
were seeded on top of the matrigel layer. Complete media 
containing 10% FBS was added to the lower chamber 
as a chemoattractant and incubated for 24 h at 37oC. 
Invaded cells were fixed with 70% ethanol for 20 min at 
room temperature and stained with 0.2% crystal violet 
for 30 min at room temperature. Invaded cells were then 
captured using Canon powershot A640 camera at 20X 
magnification for counting. At least ten representative 
fields were captured per membrane and the number of 
invaded cells were manually counted using Metamorph 
software and quantified.
Western blotting
Cells were lysed with Radioimmunoprecipitation 
assay buffer (RIPA) (Sigma-Aldrich) supplemented with 
protease inhibitors (Roche Complete protease inhibitor 
cocktail, Roche, Basel, Switzerland). Equal amount of 
lysates were separated by SDS-PAGE and transferred to a 
polyvinylidene difluoride (PVDF) membrane (Millipore, 
MA, USA). Membranes were blocked with 5% w/v milk 
(Blocking grade milk, Bio-Rad) for 1 h and incubated 
overnight at 4oC with primary antibodies against gelsolin 
(Abcam, UK), Cu/ZnSOD (Cell Signaling, MA, USA), 
MnSOD (BD), VDAC (Cell Signaling); GAPDH (BD 
Biosciences) and β-actin (Sigma-Aldrich). The membranes 
were washed and incubated with horse radish peroxidase-
conjugated secondary antibodies. Signals were visualized 
using chemiluminescence substrate (Thermo Scientific, 
MA, USA).
Immunoprecipitation
Cells were lysed with modified RIPA buffer 
(5M Nacl, 1M Tris-HCL, pH 8.0, 0.5M EDTA, 1% 
Triton X-100, 0.1% sodium deoxycholate and protease 
inhibitors). 500µg of cell lysate was incubated overnight 
with 20µL of protein A/G agarose beads (Santa Cruz, TX, 
USA) conjugated to 2µg of primary antibody against Cu/
ZnSOD at 4°C. The beads were washed three times with 
modified RIPA buffer, boiled for 10 min and the proteins 
were fractionated by SDS-PAGE followed by western 
blotting.
In situ proximity ligation assay
In situ Proximity Ligation Assay (PLA) was 
performed using the 563 Duolink detection kit (OLINK, 
Uppsala, Sweden) according to manufacturer’s 
instructions. 1 x 105 cells were grown on a 12-cm coverslip 
for 24 h. Cells were fixed with 4% parafolrmaldehyde 
for 20 min followed by blocking using 5% BSA for 1 
h at room temperature. Cells were then incubated with 
primary antibodies against gelsolin and Cu/ZnSOD at 
4°C overnight. Cells were washed and incubated with the 
PLA probes at 37°C for 1 h. The oligonucleotides were 
then ligated using the ligation reaction mixture at 37°C 
for 30 min and the ligated product was amplified using 
the red fluorescent amplification reagent at 37°C for 100 
min. Cells were washed and the coverslip was mounted 
onto a glass slide using mounting media containing DAPI 
to counterstain the nuclei. Images were captured using 
Olympus DP72 microscope and cellSens software at 40X 
and 60X magnification.
Isolation of intact mitochondria and cytosolic 
fraction
Intact mitochondria and cytosolic fractions were 
isolated as described previously [72]. Cells were grown 
to 70% confluence in a 10-cm tissue culture dish. 150µL 
of mitochondrial extraction buffer (200mM mannitol, 
68mM sucrose, 50mM Pipes-KOH pH 7.4, 50mM KCl, 
5mM EGTA, 2mM MgCl2 and 1mM dithiothreitol), 
containing protease inhibitors was added to the dishes and 
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cells were detached by scraping. The detached cells were 
transferred to 1.5mL tubes and incubated on ice for 20 
min. Cells were homogenized with a dounce homogenizer 
and passaged for 40 strokes followed by centrifugation at 
300 g for 10 min at 4ºC. The supernatant was transferred 
to a fresh eppendorf tube and centrifuged at 12000g for 30 
min at 4ºC. The pellet contains the intact mitochondrial 
fraction. The supernatant was again centrifuged at 25,000g 
for 45 min to obtain the cytosolic fraction.
Superoxide dismutase (SOD) activity assay
SOD activity was measured using the calorimetric-
based SOD activity kit (ENZO Life Sciences, NY, USA) 
according to the manufacturer’s protocol. Cells were lysed 
and 20µg protein from each sample was dispensed to a 
clear bottom 96-well plate. 150μL of WST-1 and Xanthine 
oxidase (in a master mix) was pipetted into each well and 
the reaction was then initiated by adding 25μL of 1X 
Xanthine Solution. Absorbance reading was obtained at 
450nm every minute for 10 min at room temperature. SOD 
activity of the samples were plotted against SOD standard 
curve.
In silico prediction of protein-protein interaction
Molecular Docking: Crystal structures of gelsolin 
(PDB code: 3FFN, Chain A) and Cu/ZnSOD (PDB code: 
1PU0, Chain A) were obtained form Protein Data Bank. 
Molecular docking between Gelsolin and Cu/ZnSOD was 
performed using PatchDock with default cut-off values 
[73]. PatchDock is a geometry-based molecular docking 
algorithm, which aims at finding docking confirmations 
based on the molecular shape complementarity.
Molecular dynamics: Molecular dynamics 
simulations were performed using the GROMACS 
version 4.5.3 with OPLS force field [74]. The heterodimer 
model (Gelsolin-Cu/ZnSOD complex) was placed in 
a cubic box with the box-edges at least 10nm apart 
from the protein surface. The system was solvated with 
Simple Point Charge (SPC216) water molecules and 
appropriate number of counterions was added in the box 
to neutralize the system. In order to remove the possible 
clashes between atoms, the energy minimization was set 
to run for 50000 steps or until convergence to machine 
precision. After energy minimization, simulations were 
performed for 100 ps at constant temperature and pressure 
with periodic boundary conditions, particle-mesh Ewald 
summation, and a 2-fs time step to heat and equilibrate 
the system. Then the system was subjected to production 
of MD simulations for 10 ns. Structures were saved every 
2 ps for analysis. The output files from the GROMACS 
4.5.3 was analyzed using XMGRACE software. The 
overall stability of the dimer was measured by estimating 
the root mean square deviation (RMSD) of the molecule 
and its radius of gyration (Rg).
Interactions (hydrogen bonds and hydrophobic 
forces) were analyzed at the interface in each simulated 
structure. Interactions between hydrophobic side chains 
are identified using a distance cut off of 5 Angstrom 
between apolar groups in the apolar side chains [75]. The 
hydrogen bonds formed between subunits are identified 
using HBOND program which is a part of JOY suite [76]. 
The interactions that exist in at least 60% of the simulated 
structures were considered as dynamically stable and used 
for the interpretation of stability.
Data preprocessing of microarray gene expression
Gene expression microarray data of colon cancer 
on U133A or U133Plus2 platforms were downloaded 
from Gene Omnibus (GEO), including GSE10961 (n = 
18), GSE12945 (n = 62), GSE13067 (n = 74), GSE13294 
(n = 155), GSE14333 (n = 290), GSE15960 (n = 12), 
GSE17536 (n = 177), GSE17537 (n = 55), GSE18088 (n = 
53), GSE18105 (n = 77), GSE20916 (n = 101), GSE23878 
(n = 35), GSE24514 (n = 34), GSE26682 (n = 331), 
GSE31595 (n = 37), GSE33113 (n = 90), GSE4045 (n = 
37), GSE5851 (n = 80), GSE8671 (n = 32), and GSE9348 
(n = 70). Robust Multichip Average (RMA) normalization 
was performed on each dataset. The normalized data was 
compiled and subsequently standardized using ComBat to 
remove batch effect [77]. The standardized data yielded 
a dataset of 1,820 colon carcinoma. A non-parametric 
test (Spearman’s rank correlation) was used to access the 
correlation and significance of GSN (gelsolin) with other 
factors.
Sandwiched Enzyme-linked immunosorbent assay 
(ELISA)
Cells were cultured in serum free media with 
or without 5µM DPI for 8 h. Conditioned media was 
harvested for ELISA. ELISA was performed following 
standard sandwiched ELISA methods using the uPA 
DuoSet ELISA kit (R&D Systems, MN, USA) according 
to the maufacturer’s protocol. ELISA plates were coated 
with 100µL capture antibody overnight. Wells were then 
washed thoroughly (3-5 times) with 400µL of wash 
buffer, followed by blocking the plates with 300µL 
reagent diluent for 1 h. Wells were washed three times 
with 1X wash buffer (0.05% PBST). 100µL of samples 
were dispensed to the wells and incubated for 2 h at 
room temperature. Wells were washed and 100µL of 
Streptavidin-HRP was added to each well and incubated 
for 20 min at room temperature. This was followed by 
adding 100µL of substrate solution and again incubated 
for 20 min at room temperature. The reaction was stopped 
by adding 50µL of 1M H2SO4. The optical density of each 
well was measured using ASYS UVM 340 microplate 
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reader at 450nm, using 570nm as reference wavelength.
Microscopy
Cell counting and images for Invasion assay were 
obtained using Carl Zeiss Axiovert 40 CFL - Inverted 
Microscope and images were processed Image J. 
Visualization and images for the In situ Proximity Ligation 
Assay were processed using Olympus DP72 microscope 
and cellSens software.
Intracellular calcium measurement
Vector control cells and gelsolin-overexpressing 
cells (C1) were were incubated with 5μM Fura2-AM for 
30 minutes in calcium buffer (1.8% glucose, 2% BSA, 
1mM CaCl2, 145mM NaCl, 5mM KCl, 1mM MgCl2, 
10mM Hepes pH7.4). Cells were then washed twice with 
calcium buffer and subjected to ratiometric analysis of 
Fura2-AM fluorescence using Xcellence software under 
Olympus IX73 fluorescence microscope. Intracellular 
calcium level was measured by fluorescence ratio of 
340nm/380nm (excitation at 340nm and 380nm and 
emission at 540nm) at 0.8s interval. Average value of 
340nm/380nm ratio over 3 minutes was calculated, and 
the fold changes of ratio compared to vector control cells 
were calculated.
Statistical analysis
All statistical analyses were performed using a two 
tailed Student’s t-test. Differences between sample means 
were considered statistically significant when p-value < 
0.05.
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